In a recent co-created research project spearheaded by Innovation for Change – East Asia, a comprehensive report has been released, delving into the crucial aspects of vaccine transparency and accountability across Asia. The study, conducted from the last quarter of 2022 to mid-2023, involved collaboration with 11 researchers spanning Southeast, South, and Central Asia. Its primary focus was to examine the role of vaccine access in relation to equity, diplomacy, transparency, accountability, and the initial reliance on Chinese-made vaccines.

Titled “VACCINE EQUITY, TRANSPARENCY, AND ACCOUNTABILITY IN ASIA: Realities and Dilemmas,” the report is the culmination of joint efforts by Innovation for Change – South Asia and Innovation for Change – Central Asia. Presented in English, it offers a comprehensive synthesis of findings along with a series of infographics accompanying each country report (with a Simplified Chinese translation of the reported synthesis and infographics to be made available soon).